Trials / Unknown
UnknownNCT03662828
Epidemiological Description of the Kaposi's Disease in France's Southeast
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Direction Centrale du Service de Santé des Armées · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the prevalence of the Kaposi's disease in France's southeast on 10 years (from 2007 to 2017)
Detailed description
Kaposi's disease is a multifocal disease with cutaneous expression in more than 95% of cases. There are 4 forms : Mediterranean, Endemic (Sub-Saharan Africa), iatrogenic and epidemic (HIV) The physiological hypotheses to explain the disease are not clear. A proliferation of immunity cells in blood vessels and also an undetermined role of the human herpes virus 8 (HHV-8) could be involved. The treatment is complex and not standardized. There are a lot of different treatments. The purpose of this study is to evaluate the prevalence and described the characteristics and the treatment of the Kaposi's disease in the France's southeast on 10 years, from 2007 to 2017.
Conditions
Timeline
- Start date
- 2018-08-01
- Primary completion
- 2020-08-01
- Completion
- 2020-08-01
- First posted
- 2018-09-10
- Last updated
- 2019-05-14
Locations
5 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03662828. Inclusion in this directory is not an endorsement.